Stifel downgrades Biogen due to slow launch of Alzheimer’s drugs, uncertainty ahead By Investing.comDecember 17, 20240 Investing.com — Stifel downgraded shares of Biogen Inc (NASDAQ:) from “Buy” to “Hold”, noting that the company had a rough…
Investing in Alzheimer’s research in 2023October 16, 20240 Investing in Alzheimer’s research in 2023 Source link